Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice
- 15 March 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 62 (3) , 263-271
- https://doi.org/10.1016/0304-3835(92)90105-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Biology of pancreatic cancer.Gut, 1991
- Membrane Receptors for Peptides in Experimental and Human Pancreatic CancersPancreas, 1989
- Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells.Journal of Clinical Investigation, 1989
- Receptors for luteinizing hormone‐releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasiaThe Prostate, 1989
- Potential role of somatostatin analogues in the treatment of cancerEuropean Journal of Clinical Investigation, 1987
- Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: A positron emission tomographic studyAnnals of Neurology, 1987
- Tumor measurement in the nude mouseJournal of Surgical Oncology, 1986
- A multifactorial model for pancreatic cancer in man. Epidemiologic evidencePublished by American Medical Association (AMA) ,1981
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- The clinical pharmacology of methotrexate.new applications of an old drugCancer, 1978